Diabetes Mellitus Type 1

Diabetes Mellitus Type 1: Diabetes Mellitus Type 1, often referred to as Type 1 diabetes, is an autoimmune disease where the body's immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. This results in a lack of insulin, leading to high blood sugar levels, and individuals with Type 1 diabetes require lifelong insulin therapy for blood sugar regulation.

 

  1. Insulin Therapy
  2. Immunological Mechanisms
  3. Artificial Pancreas Technology

Insulin Therapy: Insulin therapy is a cornerstone of diabetes management involving the administration of insulin to regulate blood sugar levels. It is essential for individuals with Type 1 diabetes and sometimes used in Type 2 diabetes.

Immunological Mechanisms: Immunological mechanisms refer to the processes by which the immune system is involved in the development of diseases like Type 1 diabetes, where it mistakenly attacks insulin-producing cells in the pancreas.

Artificial Pancreas Technology: Artificial pancreas technology combines continuous glucose monitoring and insulin delivery systems to automate blood sugar control, emulating the role of the pancreas in diabetes management.



 


    Related Conference of Diabetes Mellitus Type 1

    March 25-26, 2024

    5th Annual Conference on Diabetes

    London, UK
    July 11-12, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Diabetes Mellitus Type 1 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in